Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease.

MLA

Yang, Bo-Lin, et al. “Long-Term Outcome of Infliximab Combined with Surgery for Perianal Fistulizing Crohn’s Disease.” World Journal of Gastroenterology, vol. 21, no. 8, Feb. 2015, pp. 2475–82. EBSCOhost, https://doi.org/10.3748/wjg.v21.i8.2475.

APA

Yang, B.-L., Chen, Y.-G., Gu, Y.-F., Chen, H.-J., Sun, G.-D., Zhu, P., & Shao, W.-J. (2015). Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn’s disease. World Journal of Gastroenterology, 21(8), 2475–2482. https://doi.org/10.3748/wjg.v21.i8.2475

Chicago

Yang, Bo-Lin, Yu-Gen Chen, Yun-Fei Gu, Hong-Jin Chen, Gui-Dong Sun, Ping Zhu, and Wan-Jin Shao. 2015. “Long-Term Outcome of Infliximab Combined with Surgery for Perianal Fistulizing Crohn’s Disease.” World Journal of Gastroenterology 21 (8): 2475–82. doi:10.3748/wjg.v21.i8.2475.